<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Bolla, Eleana</style></author><author><style face="normal" font="default" size="100%">Semb, Anne Grete</style></author><author><style face="normal" font="default" size="100%">Petri, Michelle</style></author><author><style face="normal" font="default" size="100%">Sfikakis, Petros P.</style></author><author><style face="normal" font="default" size="100%">Artim-Esen, Bahar</style></author><author><style face="normal" font="default" size="100%">Hernandez-Molina, Gabriela</style></author><author><style face="normal" font="default" size="100%">Hachulla, Eric</style></author><author><style face="normal" font="default" size="100%">Direskeneli, Haner</style></author><author><style face="normal" font="default" size="100%">Karpouzas, George A</style></author><author><style face="normal" font="default" size="100%">Zucchi, Dina</style></author><author><style face="normal" font="default" size="100%">others</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Cardiovascular risk factor control in antiphospholipid syndrome, and differences between primary and systemic lupus erythematosus-related antiphospholipid syndrome (SURF-SLE and APS project): a cross-sectional study of 1003 individuals from 11 countries</style></title><secondary-title><style face="normal" font="default" size="100%">The Lancet Rheumatology</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2025</style></year></dates><publisher><style face="normal" font="default" size="100%">Elsevier</style></publisher><language><style face="normal" font="default" size="100%">eng</style></language></record></records></xml>